EDITAS MEDICINE INC.
3.1700
07-十一月-24 14:59:58
15 分钟延时
股票
-0.1100
-3.35%
今日范围
3.1100 - 3.3000
ISIN
N/A
来源
NASDAQ
-
07 10月 2021 07:00:01 条件 Nasdaq GlobeNewswire
-
Editas Medicine to Present at Chardan’s 5th Annual Genetic Medicines Conference
30 9月 2021 07:00:00 条件 Nasdaq GlobeNewswire
-
29 9月 2021 08:00:01 条件 Nasdaq GlobeNewswire
-
Editas Medicine Names Emma Reeve to Board of Directors
08 9月 2021 08:00:01 条件 Nasdaq GlobeNewswire
-
07 9月 2021 15:00:00 条件 Nasdaq GlobeNewswire
-
Editas Medicine to Participate in Upcoming Investor Conferences
02 9月 2021 07:00:01 条件 Nasdaq GlobeNewswire
-
20 8月 2021 15:20:00 条件 Nasdaq GlobeNewswire
-
Editas Medicine Announces Second Quarter 2021 Results and Business Updates
04 8月 2021 06:00:01 条件 Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing Second Quarter 2021 Results and Corporate Update
28 7月 2021 06:00:01 条件 Nasdaq GlobeNewswire
-
Editas Medicine Names Bruce E. Eaton, Ph.D., as Executive Vice President and Chief Business Officer
26 7月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
23 6月 2021 06:00:00 条件 Nasdaq GlobeNewswire
-
15 6月 2021 15:01:00 条件 Nasdaq GlobeNewswire
-
14 6月 2021 08:00:01 条件 Nasdaq GlobeNewswire
-
Editas Medicine Announces First Quarter 2021 Results and Update
05 5月 2021 06:00:01 条件 Nasdaq GlobeNewswire
-
Editas Medicine Names Mark S. Shearman, Ph.D., as Chief Scientific Officer
05 5月 2021 05:59:00 条件 Nasdaq GlobeNewswire
-
Editas Medicine to Host Conference Call Discussing First Quarter 2021 Results and Corporate Update
28 4月 2021 06:01:00 条件 Nasdaq GlobeNewswire